AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26073354
Drug: Linagliptin 2.5
RxNorm normalized name: linagliptin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin 2.5 mg/metformin 500 mg
Trial: 19534294
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin (10U) injection into the carpal tunnel
Trial: 17453298
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m²) every 7 days for 43 days
Trial: 17453298
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m²) and cisplatin (25 mg/m²)
Trial: 11452568
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment twice weekly for 8 weeks
Trial: 11452568
Drug: Crossover control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crossover control group receiving acupuncture treatments twice weekly for 8 weeks
Trial: 2656774
Drug: Indomethacin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75 mg daily for 3 days)
Trial: 29665733
Drug: Methylprednisolone administration
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone administration
Trial: 27681442
Drug: Lanicemine 50
RxNorm normalized name: Lanicemine
DrugBank: Lanicemine (DB11889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanicemine 50 mg
Trial: 27681442
Drug: Lanicemine 100
RxNorm normalized name: Lanicemine
DrugBank: Lanicemine (DB11889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanicemine 100 mg
Trial: 25412724
Drug: Peer-led HIV
RxNorm normalized name: HIV Integrase Inhibitor
DrugBank: HIV Integrase Inhibitor (DB16114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer-led HIV medication adherence intervention ('Ready')
Trial: 22749633
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plans compliant with SIOPEN protocol guidelines
Trial: 22749633
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plans with justifiable deviations
Trial: 22749633
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plans with justifiable deviations that might result in adverse effects
Trial: 22749633
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plans with unjustified deviations
Trial: 22749633
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plans with no discernible justification
Trial: 19188680
Drug: Low-dose bevacizumab
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bevacizumab (7.5 mg/kg) plus cisplatin/gemcitabine
Trial: 19188680
Drug: High-dose bevacizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose bevacizumab (15 mg/kg) plus cisplatin/gemcitabine
Trial: 15715249
Drug: Conventional methods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional methods (microscopic examinations of bone marrow and lymph node aspirates and immunofluorescent antibody tests)
Trial: 8841868
Drug: Fentanyl 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 7.5 micrograms/kg and midazolam 0.075 mg/kg administered over 10 minutes
Trial: 8841868
Drug: Fentanyl 12.5
RxNorm normalized name: FENTANYL 12.5MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 12.5 micrograms/kg and midazolam 0.125 mg/kg administered over 10 minutes
Trial: 8841868
Drug: Fentanyl 20.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 20.0 micrograms/kg and midazolam 0.200 mg/kg administered over 10 minutes
Trial: 8841868
Drug: Fentanyl 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 7.5 micrograms/kg and midazolam 0.075 mg/kg administered within 1 minute
Trial: 1703327
Drug: Alternate chemotherapy
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate chemotherapy (2 CHOP‐Bleo courses, 2 CMED courses, 2 CHOP‐Bleo courses)
Trial: 7351906
Drug: High-volume fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-volume fluid intake (mean excess, 47 ml per kilogram per day)
Trial: 24838406
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3
Trial: 25350959
Drug: lersivirine 750
RxNorm normalized name: Lersivirine
DrugBank: Lersivirine (DB11649)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lersivirine 750 mg qd
Trial: 25350959
Drug: lersivirine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lersivirine 1,000 mg qd
Trial: 20441724
Drug: Olanzapine (flexible-dose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (flexible-dose, mean dose 10.8 ± 5.7 mg/d)
Trial: 17922461
Drug: Conventional adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional adjuvant chemotherapy
Trial: 17922461
Drug: Dose-intensified adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-intensified adjuvant chemotherapy
Trial: 12161491
Drug: GnRH analog
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH analog therapy
Trial: 1636133
Drug: Perioperative antibiotic
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative antibiotic use
Trial: 8366411
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic
Trial: 30103187
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) - up to 20 sessions
Trial: 26718306
Drug: Depo-Provera (medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depo-Provera (medroxyprogesterone acetate), one injection every 3 months for 6 months (2 doses)
Trial: 26718306
Drug: Oral cyclic
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclic Norethisterone acetate (NETA), 15 mg daily for 14 days per cycle for 6 months
Trial: 17967583
Drug: Catheter-directed thrombolysis
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catheter-directed thrombolysis (CDT) in addition to conventional treatment
Trial: 15774775
Drug: Continuous-infusion fluorouracil
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous-infusion fluorouracil (CIFU) 250 mg/m²/d for 56 days every 9 weeks for three cycles plus levamisole 50 mg tid for 3 days every other week
Trial: 15774775
Drug: Fluorouracil (FU)
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil (FU) 425 mg/m² and leucovorin (LV) 20 mg/m² daily for 5 days every 28 to 35 days for six cycles plus levamisole 50 mg tid for 3 days every other week
Trial: 9810302
Drug: Anesthetic cream
RxNorm normalized name: DIBUCAINE/DIPERODON ANESTHETIC CREAM
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anesthetic cream combined with lidocaine infiltration
Trial: 2142428
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (600 mg per day for three months)
Trial: 22589376
Drug: CCX354-C 100
RxNorm normalized name: C-Topical 100 MG/ML Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCX354-C 100 mg twice daily
Trial: 22589376
Drug: CCX354-C 200
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CCX354-C 200 mg once daily
Trial: 21691341
Drug: Mindfulness group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness group (MG) training
Trial: 20001979
Drug: Carvedilol (monotherapy)
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol (monotherapy)
Trial: 9578521
Drug: VGB 100-150
RxNorm normalized name: VGB-R04
DrugBank: VGB-R04 (DB18615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VGB 100-150 mg/kg/day
Trial: 7526056
Drug: moexipril 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 3.75 mg
Trial: 7526056
Drug: moexipril 7.5
RxNorm normalized name: moexipril 7.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 7.5 mg
Trial: 10376852
Drug: moexipril 15
RxNorm normalized name: moexipril 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 15 mg
Trial: 3317356
Drug: Yeast-derived hepatitis
RxNorm normalized name: YEAST CELL,LIVE DERIVATIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yeast-derived hepatitis B vaccine (Engerix-B)
Trial: 22731679
Drug: Polymerized type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymerized type I collagen (PC), weekly subcutaneous intralesional injections ranging from 0.2 mL to 1.0 mL (1.66 mg to 8.3 mg collagen) for 3 months.
Trial: 22731679
Drug: Methylprednisolone (MP),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP), monthly subcutaneous intralesional injections of 0.1 mL (20 mg/mL each month) for 3 months.
Trial: 19795993
Drug: Inactive/placebo laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive/placebo laser treatment
Trial: 7574508
Drug: Cefixime 200
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 200 mg orally every 12 h for 2 days (group 1, 4 h sampling)
Trial: 7574508
Drug: Cefixime 200
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 200 mg orally every 12 h for 2 days (group 2, 12 h sampling)
Trial: 7574508
Drug: Cefixime 200
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 200 mg orally every 12 h for 2 days
Trial: 17014273
Drug: Individual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual therapy upon request
Trial: 23472957
Drug: Phonological Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonological Therapy (PT)
Trial: 23472957
Drug: Articulation Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articulation Therapy (AT)
Trial: 21592370
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (33 mg/m2)
Trial: 21592370
Drug: 3-weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly docetaxel (100 mg/m2)
Trial: 16721678
Drug: Total mesorectal
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total mesorectal excision (TME) with preoperative therapy
Trial: 16721678
Drug: Total mesorectal
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total mesorectal excision (TME) without preoperative therapy
Trial: 9391811
Drug: Epidural perineural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural perineural injections
Trial: 9391811
Drug: Epidural perineural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural perineural injections with triamcinolone (10 mg)
Trial: 9391811
Drug: Conventional posterior
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional posterior epidural injections
Trial: 2467095
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g daily of safflower oil (linoleic acid)
Trial: 29627888
Drug: High-Intensity Laser
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Laser Therapy (HILT) (1064 nm)
Trial: 29627888
Drug: Low-Level Laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Level Laser Therapy (LLLT) (904 nm)
Trial: 22069361
Drug: BDP/F 400/24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP/F 400/24 μg/day
Trial: 22069361
Drug: FP/S 500/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP/S 500/100 μg/day
Trial: 16621870
Drug: Prasugrel 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 40 mg loading dose (LD) / 5 mg maintenance dose (MD)
Trial: 16621870
Drug: Prasugrel 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 40 mg LD / 7.5 mg MD
Trial: 18217157
Drug: Clopidogrel 300
RxNorm normalized name: clopidogrel 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 300 mg LD / 75 mg MD
Trial: 24990396
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg MD
Trial: 16633079
Drug: Prasugrel 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 15 mg MD
Trial: 11709686
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (neither drug)
Trial: 3229867
Drug: Propranolol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol therapy
Trial: 20665472
Drug: E. laciniata
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E. laciniata extract ointment
Trial: 11228355
Drug: Conjugate vaccine
RxNorm normalized name: meningococcal conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugate vaccine without aluminium hydroxide adjuvant
Trial: 11228355
Drug: Conjugate vaccine
RxNorm normalized name: meningococcal conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugate vaccine with aluminium hydroxide adjuvant
Trial: 11228355
Drug: 23-valent PS
RxNorm normalized name: Streptococcus pneumoniae type 1 capsular polysaccharide antigen
DrugBank: Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent PS vaccine (control)
Trial: 11228355
Drug: Both conjugate
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both conjugate vaccines
Trial: 9508168
Drug: Mitoxantrone (MTZ)
DrugBank: Mitoxantrone (DB01204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (MTZ) 8 mg/m2 on days 1, 2, and 3 plus cytarabine (Ara‐C) 100 mg/m2 on days 1 to 7
Trial: 9508168
Drug: Daunomycin (DNR)
RxNorm normalized name: Daunomycin
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daunomycin (DNR) 30 mg/m2 on days 1, 2, and 3 plus cytarabine (Ara‐C) 100 mg/m2 on days 1 to 7
Trial: 9508168
Drug: Low-dose cytarabine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cytarabine (LD-Ara-C) 10 mg/m2 subcutaneously every 12 hours for 12 days every 6 weeks
Trial: 9508168
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment after initial chemotherapy
Trial: 9508168
Drug: Low-dose cytarabine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cytarabine (LD-Ara-C)
Trial: 8310991
Drug: Psyllium seed
RxNorm normalized name: Psyllium seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium seed (10 g/d for 3 weeks)
Trial: 8310991
Drug: Psyllium husk
RxNorm normalized name: Psyllium Husk
DrugBank: Plantago seed (DB11097)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium husk (10 g/d for 3 weeks)
Trial: 26677669
Drug: Ziyin Huoxue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziyin Huoxue Granule (ZHG) combined with glucocorticoids and antibiotics
Trial: 26677669
Drug: Glucocorticoids and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoids and antibiotics alone (Control)
Trial: 17164738
Drug: Subcutaneous preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous preoperative reviparin (4,200 anti Xa IU) once daily
Trial: 17164738
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (7,500 IU) twice daily
Trial: 10712343
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (FP) at 880 microg
Trial: 1323926
Drug: Soy phosphatidylcholine
RxNorm normalized name: hydrogenated soy phosphatidylcholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy phosphatidylcholine (PC) 27 g
Trial: 1323926
Drug: Soy phosphatidylcholine
RxNorm normalized name: hydrogenated soy phosphatidylcholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy phosphatidylcholine (PC) 18 g
Trial: 6507905
Drug: Intravenous bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bupivacaine (2 mg/min for 3 hr)
Trial: 21035214
Drug: Upstream GP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upstream GP IIb/IIIa inhibitors therapy
Trial: 20939113
Drug: STRD (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STRD (100 mg of hydrocortisone before PM and on postoperative days 1, 2, 3)
Trial: 18522627
Drug: CS-706 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CS-706 (50 mg oral dose)
Trial: 10372241
Drug: KJM fiber-enriched
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KJM fiber-enriched test biscuits (0.7 g/412 kJ [100 kcal] of glucomannan)
Trial: 29663901
Drug: Community-led surveillance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-led surveillance and treatment in intervention villages (5 villages, 997 residents)
Trial: 24154863
Drug: Standard-dose prasugrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose prasugrel (60 mg loading dose / 10 mg daily maintenance dose)
Trial: 24154863
Drug: Standard-dose prasugrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose prasugrel (10 mg daily maintenance dose)
Trial: 24154863
Drug: High-dose clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose clopidogrel (900 mg loading dose / 150 mg daily maintenance dose)
Trial: 23034424
Drug: Toothbrushing and
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toothbrushing and tongue cleaning with tooth-and-tongue gel
Trial: 20854964
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy (losartan or atenolol)
Trial: 20854964
Drug: Normal in-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal in-treatment transmitral flow pattern
Trial: 11185631
Drug: Telmisartan 120
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan 120 mg
Trial: 27612991
Drug: Doxapram dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram dosing adjusted for gender and postmenstrual age (GrA)
Trial: 27612991
Drug: Doxapram dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram dosing based on infants' weight alone (GrW)
Trial: 22248750
Drug: Lactate Ringer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactate Ringer solution (RL)
Trial: 3540872
Drug: Meperidine 50
RxNorm normalized name: meperidine 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 50 mg
Trial: 10462387
Drug: Consensus interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consensus interferon (9 microg) given three times weekly for 24 weeks
Trial: 10462387
Drug: Interferon alfa‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa‐2b (3 million units) given three times weekly for 24 weeks
Trial: 2195704
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g Almarin capsules (fish oil concentrate) daily for 12 weeks
Trial: 23359185
Drug: HDC +
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: HDC + DC/CIK (120 mg/m(2) docetaxel, 175 mg/m(2) thiotepa, with or without 400 mg/m(2) carboplatin)
Trial: 23359185
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose chemotherapy (SDC) (75 mg/m(2) docetaxel and 75 mg/m(2) thiotepa)
Trial: 12584829
Drug: Sanjin tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanjin tablet
Trial: 22097348
Drug: Conventional sensitive
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional sensitive antibiotics
Trial: 16685007
Drug: Ciclesonide treatment
RxNorm normalized name: Ciclesonide
DrugBank: Ciclesonide (DB01410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclesonide treatment groups